"10.1371_journal.pone.0085317","plos one","2014-02-04T00:00:00Z","Xinhua Yu; Junfeng Zheng; Mattias Collin; Enno Schmidt; Detlef Zillikens; Frank Petersen","Priority Area Asthma & Allergy, Research Center Borstel, Airway Research Center North (ARCN), Members of the German Center for Lung Research (DZL), Borstel, Germany; Laboratory of Autoimmunity, The Medical College of Xiamen University, Xiamen University, Xiamen, China; Division of Infection Medicine, Department of Clinical Science, Lund University, Lund, Sweden; Department of Dermatology, University of Lübeck, Lübeck, Germany","Conceived and designed the experiments: XY ES FP. Performed the experiments: XY JZ. Analyzed the data: XY DZ FP. Contributed reagents/materials/analysis tools: MC ES. Wrote the paper: XY DZ FP.","Hansa Medical AB (HM) (www.hansamedical.com) has filed patent applications for using EndoS as a treatment for antibody-mediated diseases (patents PCT/EP2007/010904 and PCT/EP2009/008215). MC is listed as one of the inventors on these applications and have a royalty agreement with HM. MC is a scientific consultant for HM through his sole proprietorship GlycImmun (GI) (www.glycimmun.com). HM and GI were not involved in any way in the design of the study, writing of the manuscript or the decision to publish. The authors will without exceptions adhere to all the PLOS ONE policies on sharing data and materials.","2014","02","Xinhua Yu","XY",6,TRUE,3,2,3,3,TRUE,TRUE,FALSE,0,NA,FALSE
